| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/HIV.12045 |
| P698 | PubMed publication ID | 23672663 |
| P50 | author | Brian Rice | Q55762384 |
| P2093 | author name string | R D Simmons | |
| B C Ciancio | |||
| V C Delpech | |||
| M M Kall | |||
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras | Q30482995 | ||
| Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
| Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms. | Q34192156 | ||
| Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies | Q34228103 | ||
| Changes in the risk of death after HIV seroconversion compared with mortality in the general population | Q34791057 | ||
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study | Q35316315 | ||
| CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE | Q35842386 | ||
| Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years | Q36887481 | ||
| The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology | Q37869306 | ||
| Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. | Q38462726 | ||
| Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. | Q39383296 | ||
| Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion | Q40346109 | ||
| Late presentation of HIV infection: a consensus definition | Q43792060 | ||
| A prospective study of mortality among drug misusers during a 4-year period after seeking treatment | Q43918240 | ||
| Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. | Q44323501 | ||
| Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action | Q44412085 | ||
| Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. | Q45161155 | ||
| HIV transmission and high rates of late diagnoses among adults aged 50 years and over | Q45549222 | ||
| Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy | Q46276400 | ||
| Morbidity and mortality from heroin dependence. 2. Study of 100 consecutive inpatients | Q49226735 | ||
| Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
| Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. | Q51709478 | ||
| Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 | ||
| The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004) | Q57181102 | ||
| Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers | Q57181131 | ||
| No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002) | Q57181176 | ||
| Drug-related mortality and its impact on adult mortality in eight European countries | Q57209662 | ||
| Projected life expectancy of people with HIV according to timing of diagnosis | Q57476832 | ||
| P433 | issue | 10 | |
| P921 | main subject | HIV/AIDS | Q12199 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 596-604 | |
| P577 | publication date | 2013-05-15 | |
| P1433 | published in | HIV Medicine | Q15756376 |
| P1476 | title | Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer | |
| P478 | volume | 14 |
| Q55191623 | A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study. |
| Q30244921 | Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions |
| Q35189562 | Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study |
| Q61808718 | Cause-specific mortality among HIV-infected people in Ontario, 1995-2014: a population-based retrospective cohort study |
| Q35996804 | Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era |
| Q37689076 | Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report |
| Q40627202 | HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals |
| Q40253399 | HIV/AIDS-related deaths in China, 2000-2012. |
| Q41387994 | Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland. |
| Q55512108 | Magnitude of opportunistic diseases and their predictors among adult people living with HIV enrolled in care: national level cross sectional study, Ethiopia. |
| Q33713778 | Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989-2012. |
| Q51777203 | Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. |
| Q89627154 | Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan |
| Q39361290 | Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study. |
| Q49030424 | Place of death for people with HIV: a population-level comparison of eleven countries across three continents using death certificate data |
| Q55129672 | Predictors of human immunodeficiency virus (HIV) infection in primary care among adults living in developed countries: a systematic review. |
| Q36137693 | Predictors of human immunodeficiency virus (HIV) infection in primary care: a systematic review protocol |
| Q42246625 | Quality of HIV care in the United Kingdom: key indicators for the first 12 months from HIV diagnosis |
| Q52638828 | Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy. |
| Q34823231 | Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America |
| Q99586558 | The Epidemiology of HIV in Oman, 1984-2018: A Nationwide Study from the Middle East |
| Q92799000 | The Impact of "Churn" on Plasma HIV Burden Within a Population Under Care |
| Q47801305 | The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013. |
| Q90087187 | Tobacco smoking and alcohol drinking among HIV infected people using antiretroviral therapy |
| Q36123049 | Trends and Predictors of Mortality Among HIV Positive Patients in the Era of Highly Active Antiretroviral Therapy in Uganda |
| Q36192956 | Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012). |
Search more.